The company combines molecular diagnostics with high throughput cellular analysis to offer single-cell testing of proteomic and genomic biomarkers for critical diseases such as HIV/AIDS, HPV/Cervical Cancer, Hepatitis, organ transplant infections, breast cancer, and ovarian cancer. Their diagnostics provide physicians with a hassle-free way to access vital information for better patient care.